1. The development of folate-functionalised palladium nanoparticles for folate receptor targeting in breast cancer cells.
- Author
-
Gandidzanwa S, Beukes N, Joseph SV, Janse Van Vuuren A, Mashazi P, Britton J, Kilian G, Roux S, Nyokong T, Lee ME, Frost CL, and Tshentu ZR
- Subjects
- Humans, Female, Palladium pharmacology, Folic Acid chemistry, MCF-7 Cells, Cell Line, Tumor, Breast Neoplasms drug therapy, Breast Neoplasms metabolism, Metal Nanoparticles chemistry, Nanoparticles chemistry
- Abstract
Folate receptor-targeted therapy has excellent prospects for the treatment of breast cancer. A non-toxic concentration of folate-conjugated palladium-based nanoparticles was used to target the overexpressed folate receptor on breast cancer cells. The folate-conjugated nanoparticles were tailored to accumulate selectively in cancer cells relative to normal cells via the folate receptor. The MDA-MB-231, MDA-MB-468, MCF-7 breast cancer cell lines, and MCF-10A normal cell lines were used in the study. Qualitative and quantitative analysis of nanoparticle cellular uptake and accumulation was conducted using transmission electron microscopy and inductively coupled plasma-optical emission spectroscopy. The findings proved that folate-conjugated palladium nanoparticles successfully and preferentially accumulated in breast cancer cells. We conclude that folate-conjugated palladium nanoparticles can be potentially used to target breast cancer cells for radiopharmaceutical applications., (© 2023 IOP Publishing Ltd.)
- Published
- 2023
- Full Text
- View/download PDF